2020
DOI: 10.3389/fphar.2020.00097
|View full text |Cite
|
Sign up to set email alerts
|

Maternal 25-Hydroxyvitamin D Deficiency Promoted Metabolic Syndrome and Downregulated Nrf2/CBR1 Pathway in Offspring

Abstract: Metabolic syndrome is a disorder of energy use and storage, which is characterized by central obesity, dyslipidemia, and raised blood pressure and blood sugar levels. Maternal 25-hydroxyvitamin D deficiency is known to cause metabolic changes, chronic disease, and increased adiposity in adulthood. However, the underlying mechanism of induced metabolic syndrome (MetS) in the offspring in vitamin D deficient pregnant mothers remains unclear. We identified that maternal 25-hydroxyvitamin D deficiency enhances oxi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 40 publications
(45 reference statements)
0
7
0
Order By: Relevance
“…Numerous studies have reported that VD insufficiency or deficiency increases the risk of MetS [ 127 ] and that VD supplementation improves outcomes in patients, including improving insulin sensitivity and β-cell function, decreasing fasting glucose level, insulin, and hemoglobin A1c (HbA1c), increasing HDL level and reducing LDL and TG, and reducing the incidence of type 2 diabetes [ 128 ]. As in pregnant individuals and their babies, a rat model suggested that maternal VD deficiency promotes MetS in both mothers and offspring, and VD treatment may attenuate the offspring’s MetS [ 129 ].…”
Section: The Relationship Of Vd Deficiency During Pregnancy and Obesi...mentioning
confidence: 99%
“…Numerous studies have reported that VD insufficiency or deficiency increases the risk of MetS [ 127 ] and that VD supplementation improves outcomes in patients, including improving insulin sensitivity and β-cell function, decreasing fasting glucose level, insulin, and hemoglobin A1c (HbA1c), increasing HDL level and reducing LDL and TG, and reducing the incidence of type 2 diabetes [ 128 ]. As in pregnant individuals and their babies, a rat model suggested that maternal VD deficiency promotes MetS in both mothers and offspring, and VD treatment may attenuate the offspring’s MetS [ 129 ].…”
Section: The Relationship Of Vd Deficiency During Pregnancy and Obesi...mentioning
confidence: 99%
“…To selectively inhibit lung cancer, Yang et al further developed their tandem self-assembly approach. 481 As shown in Figure 78C, they designed a peptide derivative, NBD-GFF p YG-N=N-ERGD (233), which was the substrate of both ALP and reductase. According to the authors, ectoenzyme, ALP, converts 233 to NBD-GFFYG-N=N-ERGD (234).…”
Section: Peri/intracellular Ensmentioning
confidence: 99%
“…They observed that decreased expression of Nrf2/CBR1 pathway is one of the causes of oxidative stress leading to metabolic syndrome in both mothers and their offspring. 55 Multiple reports indicating Nrf2's role in GDM have led to investigations examining Nrf2 as a potential therapeutic target to improve maternal and neonatal outcomes in patients with GDM and metabolic syndrome. Metformin restored the GDM-induced impairment of angiogenesis in the placenta.…”
Section: 25mentioning
confidence: 99%